March 2023 formulary update - effective March 24, 2023
Included in the update:
Newsroom
NH laboratory services is investigating making revisions to the Drugs of Abuse (DOA) test panels offered in our region, and are seeking stakeholder feedback.
The issue: Methotrimeprazine 25 mg/mL x 1 mL injectable is available but still in short supply. NH pharmacy is able to access stock on a weekly basis, but it may not be enough to meet local demand.
The issue: Several pediatric oral antibiotic suspensions remain on shortage in Canada, but NH supply has improved with intermittent stock available for pharmacies to order. NH pharmacy continues to monitor supply closely due to continued instability in the supply chain.
The issue: Calcitonin 200 units/mL X 2 mL injectable remains on backorder from the only manufacturer in Canada, with an estimated resupply date pushed out to August 2023.This is a low use item in NH, but there will likely be a supply gap of several months leading up to the resupp
The issue: Due to current shortages of ketamine 2 mL vials (both 10 mg/mL and 50 mg/mL) and uncertainty around future supply of larger vials (10 mg/mL X 20 mL and 50 mg/mL X 10 mL), conservation measures should be implemented to prevent future stock outs.
Starting January 31, 2023, adults 18 and older in BC will not be subject to criminal charges for the possession of a cumulative total of up to 2.5 grams of certain otherwise-illegal drugs for personal use: opioids, including fentanyl and heroin; crack and powder cocaine; methamphetamine; and MDMA